Panacea Biotec Ltd.
Panacea Biotec Ltd.
- ENG - English
- HIN - हिन्दी
- GUJ - ગુજરાતી
- MAR - मराठी
- BEN - বাংলা
- KAN - ಕನ್ನಡ
- ORI - ଓଡିଆ
- TEL - తెలుగు
- TAM - தமிழ்
- NSE15:56 | 11-11-2019
- BSE15:41 | 11-11-2019
Panacea Biotec Ltd. Quarterly Results
Panacea Biotec Ltd Share Price
Panacea Biotec Ltd Risk Return Comparisonwith peersNew
Panacea Biotec Ltd Financial Comparisonwith peers
Panacea Biotec Ltd Share Holding as on 30-09-2019
|Category||No. of shares||Percentage|
MF Ownership Of Panacea Biotec Ltd. Shares
Liquid, Ultra Short Term funds and FMPs are not taken into account.More Schemes
About Panacea Biotec Ltd.
Panacea Biotec Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 836.69 Crore) operating in Pharmaceuticals sector.
Panacea Biotec Ltd. key Products/Revenue Segments include Pharmaceutical Preparations which contributed Rs 556.46 Crore to Sales Value (95.95 % of Total Sales), Other Operating Revenue which contributed Rs 11.04 Crore to Sales Value (1.90 % of Total Sales), Export Incentives which contributed Rs 6.46 Crore to Sales Value (1.11 % of Total Sales), Sale of services which contributed Rs 5.67 Crore to Sales Value (0.97 % of Total Sales) and Scrap which contributed Rs .30 Crore to Sales Value (0.05 % of Total Sales)for the year ending 31-Mar-2018.
For the quarter ended 30-06-2019, the company has reported a Consolidated sales of Rs 125.78 Crore, up 5.17 % from last quarter Sales of Rs 119.60 Crore and up 26.69 % from last year same quarter Sales of Rs 99.28 Crore Company has reported net profit after tax of Rs -28.34 Crore in latest quarter.
The company’s top management includes Dr.Rajesh Jain, Mr.Ankesh Jain, Mr.Ashwini Luthra, Mr.Bhupinder Singh, Mr.K M Lal, Mr.Mukul Gupta, Mr.N N Khamitkar, Mr.Nithin Krishna Kaimal, Mr.R L Narasimhan, Mr.Sandeep Jain, Mr.Soshil Kumar Jain, Mr.Sumit Jain, Mrs.Manjula Upadhyay, Mrs.Sunanda Jain. Company has Walker Chandiok & Co. LLP as its auditoRs As on 30-09-2019, the company has a total of 61,250,746 shares outstanding.